Kronos Bio, Inc.·4

Feb 17, 5:21 PM ET

Dinsmore Christopher 4

4 · Kronos Bio, Inc. · Filed Feb 17, 2022

Insider Transaction Report

Form 4
Period: 2022-02-15
Dinsmore Christopher
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2022-02-15+43,550128,524 total
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-15+65,00065,000 total
    Exercise: $7.08Exp: 2032-02-14Common Stock (65,000 underlying)
Footnotes (1)
  • [F1]1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION